Just read a headline about a Senator blocking the President's appointee to head the FDA. The guy is currently #2 at the agency and, at one time, was a cardiologist and researcher at Duke U. A quick search found that Duke was doing research with anatabine in 1998. I wonder if this new guy (Califf, I think)knows about anatabine and, if so, if he knows about later research relating to inflammation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.